Immune 73: Big macs
Immune
The Potential Influence of Duplimumab on COVID-19 Severity
The chapter explores the question of whether the use of Duplimumab, an eczema injection containing IL-4 and IL-13 blockers, could lead to a more severe case of COVID-19. The hosts discuss the lack of studies on this specific drug and its effects on the virus, and mention the potential role of type two responses in modulating infections.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
